AIM ImmunoTech, Inc. (AIM)
1.37
-0.08
(-5.52%)
USD |
NYAM |
Dec 12, 16:00
1.36
-0.01
(-0.73%)
After-Hours: 20:00
AIM ImmunoTech Research and Development Expense (Quarterly): 0.525M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Agenus, Inc. | 23.60M |
| Curis, Inc. | 6.432M |
| Halozyme Therapeutics, Inc. | 17.25M |
| Protalix Biotherapeutics, Inc. | 4.467M |
| Armata Pharmaceuticals, Inc. | 5.824M |